Find Scholarly Works

Search in all content

Filters for Scholarly Works

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

Author

  • Keith Lindor
2016

Ursodeoxycholic acid treatment in primary sclerosing cholangitis

Tabibian, J. H. & Lindor, K., Jan 1 2016, Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Developments. Springer International Publishing, p. 145-152 8 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis

Hilscher, M., Enders, F. B., Carey, E. J., Lindor, K. & Tabibian, J. H., Mar 1 2016, In : Annals of Hepatology. 15, 2, p. 246-253 8 p.

Research output: Contribution to journalArticle

25 Scopus citations
2018

Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis

Ponsioen, C. Y., Lindor, K., Mehta, R. & Dimick-Santos, L., Sep 1 2018, In : Hepatology. 68, 3, p. 1174-1188 15 p.

Research output: Contribution to journalReview article

16 Scopus citations
2016

Joint society statement for the elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Oct 1 2016, In : Hepatology. 64, 4, p. 1031-1032 2 p.

Research output: Contribution to journalEditorial

4 Scopus citations
2019

NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A nebulous matter

Tabibian, J. H. & Lindor, K., Jan 1 2019, (Accepted/In press) In : Journal of Hepatology.

Research output: Contribution to journalArticle

3 Scopus citations
2020

Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary Cholangitis

FOLD Investigators, Feb 1 2020, In : The American journal of gastroenterology. 115, 2, p. 262-270 9 p.

Research output: Contribution to journalArticle

2019

Current and promising therapy for primary biliary cholangitis

Gossard, A. A. & Lindor, K., Jun 13 2019, In : Expert Opinion on Pharmacotherapy. 20, 9, p. 1161-1167 7 p.

Research output: Contribution to journalReview article

3 Scopus citations
2017

Combination therapy of all-trans retinoic acid with ursodeoxycholic acid in patients with primary sclerosing cholangitis: A human pilot study

Assis, D. N., Abdelghany, O., Cai, S. Y., Gossard, A. A., Eaton, J. E., Keach, J. C., Deng, Y., Setchell, K. D. R., Ciarleglio, M., Lindor, K. & Boyer, J. L., Jan 1 2017, In : Journal of Clinical Gastroenterology. 51, 2, p. e11-e16

Research output: Contribution to journalArticle

16 Scopus citations
2019

Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices

Dong, T. S., Kalani, A., Aby, E. S., Le, L., Luu, K., Hauer, M., Kamath, R., Lindor, K. & Tabibian, J. H., Aug 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 9, p. 1894-1901.e1

Research output: Contribution to journalArticle

3 Scopus citations

Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry

Kuo, A., Gomel, R., Safer, R., Lindor, K., Everson, G. T. & Bowlus, C. L., Jun 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 7, p. 1372-1378 7 p.

Research output: Contribution to journalArticle

2 Scopus citations

Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study

Eaton, J. E., Nelson, K. M., Gossard, A. A., Carey, E. J., Tabibian, J. H., Lindor, K. D. & LaRusso, N. F., May 4 2019, In : Scandinavian Journal of Gastroenterology. 54, 5, p. 633-639 7 p.

Research output: Contribution to journalArticle

6 Scopus citations
2016

Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis

Juliusson, G., Imam, M., Björnsson, E. S., Talwalkar, J. A. & Lindor, K., Jun 2 2016, In : Scandinavian Journal of Gastroenterology. 51, 6, p. 745-752 8 p.

Research output: Contribution to journalArticle

12 Scopus citations
2020

Primary Biliary Cholangitis: 2018 Practice Guidance From the American Association for the Study of Liver Diseases

Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C. & Mayo, M., Jan 1 2020, In : Clinical Liver Disease. 15, 1, p. 1-2 2 p.

Research output: Contribution to journalEditorial

Open Access
2016

Advances in primary sclerosing cholangitis

Horsley-Silva, J. L., Carey, E. J. & Lindor, K., 2016, In : The Lancet Gastroenterology and Hepatology. 1, 1, p. 68-77 10 p.

Research output: Contribution to journalReview article

11 Scopus citations

Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: A multicentre international study

Trivedi, P. J., Lammers, W. J., Van Buuren, H. R., Parés, A., Floreani, A., Janssen, H. L. A., Invernizzi, P., Battezzati, P. M., Ponsioen, C. Y., Corpechot, C., Poupon, R., Mayo, M. J., Burroughs, A. K., Nevens, F., Mason, A. L., Kowdley, K. V., Lleo, A., Caballeria, L., Lindor, K., Hansen, B. E. & 1 others, Hirschfield, G. M., Feb 1 2016, In : Gut. 65, 2, p. 321-329 9 p.

Research output: Contribution to journalArticle

72 Scopus citations
2017

Old and new treatments for primary biliary cholangitis

Chascsa, D., Carey, E. J. & Lindor, K., Apr 1 2017, In : Liver International. 37, 4, p. 490-499 10 p.

Research output: Contribution to journalArticle

20 Scopus citations
2020

Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis

Global Primary Biliary Cholangitis Study Group, Mar 2020, In : Clinical Gastroenterology and Hepatology. 18, 3, p. 684-692.e6

Research output: Contribution to journalArticle

2019

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

the GLOBAL PBC Study Group, Nov 1 2019, In : Alimentary Pharmacology and Therapeutics. 50, 10, p. 1127-1136 10 p.

Research output: Contribution to journalArticle

Open Access
6 Scopus citations
2018

Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis: Risk factors and time trends in incidence and outcome

Harms, M. H., Lammers, W. J., Thorburn, D., Corpechot, C., Invernizzi, P., Janssen, H. L. A., Battezzati, P. M., Nevens, F., Lindor, K., Floreani, A., Ponsioen, C. Y., Mayo, M. J., Dalekos, G. N., Bruns, T., Parés, A., Mason, A. L., Verhelst, X., Kowdley, K. V., Goet, J. C., Hirschfield, G. M. & 2 others, Hansen, B. E. & Van Buuren, H. R., Feb 1 2018, In : American Journal of Gastroenterology. 113, 2, p. 254-264 11 p.

Research output: Contribution to journalArticle

24 Scopus citations
2019

Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis

Harms, M. H., De Veer, R. C., Lammers, W. J., Corpechot, C., Thorburn, D., Janssen, H. L. A., Lindor, K. D., Trivedi, P. J., Hirschfield, G. M., Pares, A., Floreani, A., Mayo, M. J., Invernizzi, P., Battezzati, P. M., Nevens, F., Ponsioen, C. Y., Mason, A. L., Kowdley, K. V., Hansen, B. E., Buuren, H. R. V. & 1 others, Van Der Meer, A. J., 2019, (Accepted/In press) In : Gut. 319057.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations
2020

Open-label prospective therapeutic clinical trials: oral vancomycin in children and adults with primary sclerosing cholangitis

Ali, A. H., Damman, J., Shah, S. B., Davies, Y., Hurwitz, M., Stephen, M., Lemos, L. M., Carey, E. J., Lindor, K. D., Buness, C. W., Alrabadi, L., Berquist, W. E. & Cox, K. L., 2020, In : Scandinavian Journal of Gastroenterology. p. 1-10 10 p.

Research output: Contribution to journalArticle

2018

Primary sclerosing cholangitis, part 1: Epidemiology, etiopathogenesis, clinical features, and treatment

Tabibian, J. H., Ali, A. H. & Lindor, K., May 1 2018, In : Gastroenterology and Hepatology. 14, 5, p. 293-304 12 p.

Research output: Contribution to journalArticle

7 Scopus citations
2016

Novel treatments in primary sclerosing cholangitis

Ali, A. H. & Lindor, K., Nov 1 2016, In : Clinical Liver Disease. 8, 5, p. 132-135 4 p.

Research output: Contribution to journalReview article

1 Scopus citations

Shifting Paradigms: What Is the True Prevalence and Clinical Course of Primary Sclerosing Cholangitis?

Weersma, R. K. & Lindor, K., Oct 1 2016, In : Gastroenterology. 151, 4, p. 590-593 4 p.

Research output: Contribution to journalEditorial

5 Scopus citations
2017

Joint society statement for elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Jan 1 2017, In : Annals of Hepatology. 16, 1, p. 6-7 2 p.

Research output: Contribution to journalEditorial

2 Scopus citations

Curcumin in hepatobiliary disease: Pharmacotherapeutic properties and emerging potential clinical applications

Hu, R. W., Carey, E. J., Lindor, K. & Tabibian, J. H., Nov 1 2017, In : Annals of Hepatology. 16, 6, p. 835-841 7 p.

Research output: Contribution to journalArticle

15 Scopus citations
2018

Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

Lindor, K., Bowlus, C. L., Boyer, J., Levy, C. & Mayo, M., Jan 1 2018, (Accepted/In press) In : Hepatology.

Research output: Contribution to journalArticle

70 Scopus citations

Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Younossi, Z. M., Loomba, R., Rinella, M. E., Bugianesi, E., Marchesini, G., Neuschwander-Tetri, B. A., Serfaty, L., Negro, F., Caldwell, S. H., Ratziu, V., Corey, K. E., Friedman, S. L., Abdelmalek, M. F., Harrison, S. A., Sanyal, A. J., Lavine, J. E., Mathurin, P., Charlton, M. R., Chalasani, N. P., Anstee, Q. M. & 4 others, Kowdley, K. V., George, J., Goodman, Z. D. & Lindor, K., Jul 2018, In : Hepatology. 68, 1, p. 361-371 11 p.

Research output: Contribution to journalReview article

97 Scopus citations
2016

Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study

PURIFI Study Group, Jul 1 2016, In : Hepatology. 64, 1, p. 189-199 11 p.

Research output: Contribution to journalArticle

51 Scopus citations
2018

Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

Younossi, Z. M., Loomba, R., Anstee, Q. M., Rinella, M. E., Bugianesi, E., Marchesini, G., Neuschwander-Tetri, B. A., Serfaty, L., Negro, F., Caldwell, S. H., Ratziu, V., Corey, K. E., Friedman, S. L., Abdelmalek, M. F., Harrison, S. A., Sanyal, A. J., Lavine, J. E., Mathurin, P., Charlton, M. R., Goodman, Z. D. & 4 others, Chalasani, N. P., Kowdley, K. V., George, J. & Lindor, K., Jul 2018, In : Hepatology. 68, 1, p. 349-360 12 p.

Research output: Contribution to journalReview article

98 Scopus citations

Editorial: Itching to Know: Role of Fibrates in PBC

Levy, C. & Lindor, K., Jan 1 2018, In : The American journal of gastroenterology. 113, 1, p. 56-57 2 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses?

Tabibian, J. H. & Lindor, K., Apr 1 2018, In : Alimentary Pharmacology and Therapeutics. 47, 8, p. 1226-1227 2 p.

Research output: Contribution to journalEditorial

1 Scopus citations
2019

Cancer risk, screening and surveillance in primary sclerosing cholangitis

Chascsa, D. M. & Lindor, K. D., Sep 1 2019, In : Minerva gastroenterologica e dietologica. 65, 3, p. 214-228 15 p.

Research output: Contribution to journalArticle

2 Scopus citations

Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease

Palmer, M., Regev, A., Lindor, K., Avigan, M. I., Dimick-Santos, L., Treem, W., Marcinak, J. F., Lewis, J. H., Anania, F. A., Seekins, D., Shneider, B. L. & Chalasani, N., Jan 1 2019, (Accepted/In press) In : Alimentary Pharmacology and Therapeutics.

Research output: Contribution to journalReview article

Open Access
2017

An update on cancer risk and surveillance in primary sclerosing cholangitis

Horsley-Silva, J. L., Rodriguez, E. A., Franco, D. L. & Lindor, K., 2017, (Accepted/In press) In : Liver International.

Research output: Contribution to journalArticle

20 Scopus citations
2018

Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems

FOLD Investigators, Jan 1 2018, (Accepted/In press) In : Clinical Gastroenterology and Hepatology.

Research output: Contribution to journalArticle

11 Scopus citations
2017

Heterogeneity of Outcomes Following Liver Transplantation for Primary Sclerosing Cholangitis: Age Matters

Martin, P. & Lindor, K., Sep 30 2017, (Accepted/In press) In : Digestive Diseases and Sciences. p. 1-2 2 p.

Research output: Contribution to journalArticle

2 Scopus citations

Emerging treatments for primary sclerosing cholangitis

Rodriguez, E. A., Carey, E. J. & Lindor, K., May 4 2017, In : Expert Review of Gastroenterology and Hepatology. 11, 5, p. 451-459 9 p.

Research output: Contribution to journalReview article

7 Scopus citations
2016

Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH)

Chawla, K. S., Talwalkar, J. A., Keach, J. C., Malinchoc, M., Lindor, K. & Jorgensen, R., Dec 31 2016, In : BMJ Open Gastroenterology. 3, 1, e000069.

Research output: Contribution to journalArticle

19 Scopus citations

Emerging drugs for the treatment of Primary Biliary Cholangitis

Ali, A. H., Tabibian, J. H., Carey, E. J. & Lindor, K., Jan 2 2016, In : Expert Opinion on Emerging Drugs. 21, 1, p. 39-56 18 p.

Research output: Contribution to journalArticle

12 Scopus citations
2017

A Randomized, Placebo-Controlled Clinical Trial of Efficacy and Safety: Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis

Silveira, M. G., Gossard, A. A., Stahler, A. C., Jorgensen, R. A., Petz, J. L., Ali, A. H. & Lindor, K., Mar 1 2017, In : American Journal of Therapeutics. 24, 2, p. e167-e176

Research output: Contribution to journalArticle

16 Scopus citations
2018

Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis

Ali, A. H., Tabibian, J. H., Nasser-Ghodsi, N., Lennon, R. J., DeLeon, T., Borad, M. J., Hilscher, M., Silveira, M. G., Carey, E. J. & Lindor, K., Jun 1 2018, In : Hepatology. 67, 6, p. 2338-2351 14 p.

Research output: Contribution to journalArticle

27 Scopus citations

Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis

Damman, J. L., Rodriguez, E. A., Ali, A. H., Buness, C. W., Cox, K. L., Carey, E. J. & Lindor, K., Apr 1 2018, In : Alimentary Pharmacology and Therapeutics. 47, 7, p. 886-895 10 p.

Research output: Contribution to journalReview article

21 Scopus citations
2017

Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

on behalf of the & International PSC Study Group, Jun 2017, In : Gastroenterology. 152, 8, p. 1975-1984.e8

Research output: Contribution to journalArticle

119 Scopus citations
2018

Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history

on behalf of the GLOBAL PBC Study Group, May 2018, In : Hepatology. 67, 5, p. 1920-1930 11 p.

Research output: Contribution to journalArticle

12 Scopus citations
2019
8 Scopus citations
2018

Emerging therapeutic targets for primary sclerosing cholangitis

Kalani, A., Tabibian, J. H. & Lindor, K., Jul 3 2018, In : Expert Opinion on Orphan Drugs. 6, 7, p. 393-401 9 p.

Research output: Contribution to journalReview article

2016

Joint society statement for the elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Oct 1 2016, In : Journal of Hepatology. 65, 4, p. 661-662 2 p.

Research output: Contribution to journalEditorial

1 Scopus citations

Distinguishing immunoglobulin G4–related disease from its pancreatobiliary mimics: Are we there now?

Tabibian, J. H. & Lindor, K., Aug 1 2016, In : Hepatology. 64, 2, p. 340-343 4 p.

Research output: Contribution to journalEditorial

6 Scopus citations
2018

Antimitochondrial Antibody–Negative Primary Biliary Cholangitis: Is It Really the Same Disease?

Chascsa, D. M. & Lindor, K., Jan 1 2018, (Accepted/In press) In : Clinics in Liver Disease.

Research output: Contribution to journalArticle

3 Scopus citations